Related Experiment Video
Updated: Feb 25, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
FIBRIN AND FIBRINOGEN DEGRADATION PRODUCTS IN MALIGNANCY
Ramji Rai1, Brig Skbasu2, M P Jaiprakash3
1Prof & Head, Dept of Pathology, AFMC Pune - 411 040.
Abstract:
Sixty four patients of cancer, comprising of 39 leukaemia, 8 lymphomas and 17 cases of solid tumours were included in this study. Quantitative estimation of FDP, fibrinogen and platelets were done in all. Elevated levels of FDP (≥ 10 µgm/mL) were found in 29 patients. These patients were further categorised as decompensated, overcompensated and compensated intravascular coagulation and fibrinolytic syndrome on the basis of platelet counts and fibrinogen levels.
Related Concept Videos
Clot Retraction and Fibrinolysis
Intracellular Signaling Affects Focal Adhesions
Some...
The Tumor Microenvironment
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...

